Yeah I’ve noticed the same pattern, it seems to be building for...

Yeah I’ve noticed the same pattern, it seems to be building for a breakout after a few weeks of consolidation.

As I’ve said previously - my numbers have the company at A$4.50ps without Didipio and if it comes on I think it’s worth a further $1.50ps. These are the plays I like the most, limited downside with almost a free option.

Also looking forward to the Waihi studies to hit the market which shouldn’t be too far away, plenty of upside there that I don’t think is priced in (in some instances understandably).